Andrei Georgescu is the founder of Vivodyne. Vivodyne has raised $80M in total funding. Latest round: Series A. Based in South San Francisco, CA.
Andrei Georgescu, Ph.D., is the Co-founder and CEO of Vivodyne, a biotechnology company that develops lab-grown 3D human tissues for preclinical drug testing. He earned his Bioengineering PhD from the University of Pennsylvania, where Vivodyne originated as a spinout founded in 2020 alongside Dan Huh, an associate professor and pioneer of organ-on-a-chip technology.
Full founder directory · Investor directory · Company funding database · Fundraising library